State Policies Regulating Law Enforcement Access to Prescription Drug Monitoring Program Testosterone Prescription Data

Katie McCreedy; Jule von der Heydt; Aanchalika Chauhan; Rajvi Shah; Sunyou Kang; Elizabeth Platt; Leo Beletsky

doi:10.1001/jama.2024.20035

State Policies Regulating Law Enforcement Access to Prescription Drug Monitoring Program Testosterone Prescription Data

JAMA. 2024 Nov 26;332(20):1754-1757. doi: 10.1001/jama.2024.20035.

Authors

Katie McCreedy^{1

2}, Jule von der Heydt¹, Aanchalika Chauhan¹, Rajvi Shah¹, Sunyou Kang¹, Elizabeth Platt³, Leo Beletsky^{1

2}

Affiliations

¹ Action Lab, Northeastern University School of Law, Boston, Massachusetts.
² Bouvé College of Health Sciences, Northeastern University, Boston, Massachusetts.
³ Center for Public Health Law Research, Temple University Beasley School of Law, Philadelphia, Pennsylvania.

No abstract available

Plain language summary

This study identifies state policies authorizing law enforcement access to prescription drug monitoring program data and discusses the characteristics of those policies, particularly in states with laws banning gender-affirming care.